Please login to the form below

US market

This page shows the latest US market news and features for those working in and with pharma, biotech and healthcare.

Pharma’s R&D productivity sinks to a new low

At the same time, the returns from these assets once they reach the market has also declined: forecast peak sales per product have almost halved in eight years, down from $816m ... all-important US market.

Latest news

J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial

the market with sales topping $2bn in the first nine months of 2018. ... in that period, with J&J claiming a 5.8% market share in the US.
Dutch biotech Argenx claims $1.8bn licensing deal with J&J

the early stage of the programme and also that Argenx is also retaining co-promotion rights in the US. ... In that market the companies have agreed to share economics 50/50 on a royalty basis, while Argenx will get double-digit sales royalties elsewhere.
FDA fast tracks Novartis’ SMA gene therapy

Novartis is expected to provide tough competition for Biogen and its first-to-market SMA treatment, Spinraza. ... The anti-sense oligonucleotide therapy has seen strong uptake since it was launched in 2017, and earned third-quarter sales of $468m ($224m
Shire’s angioedema drug Takhzyro claims EU approval

Almost all sales come from the US market, mainly because of supply constraints for Cinryze in recent years. ... Analysts at Bernstein recently predicted that Takhzyro will eventually dominate the HAE prophylaxis market with a 70% share.
Chi-Med and Lilly’s cancer drug Elunate a milestone for China

Chi-Med has achieved a major milestone for itself and China’s fast-developing pharma market, announcing today the launch of cancer treatment Elunate (fruquintinib) in the country. ... The company has ambitions beyond its home market, and wants to

More from news
Approximately 1 fully matching, plus 742 partially matching documents found.

Latest Intelligence

Is China ready for a pharmaceutical gold rush?

Rapidly growing sector. The US alone holds over 45% of the global pharmaceutical market. ... Indeed, BMS will pitch Opdivo at half the US list price, determining the true value of market access.
The handover: Pfizer reshapes itself for a new era

For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for
China: AstraZeneca’s new engine for growth and innovation

So how long before China eclipses the European market as the second most important behind the US? ... Roxadustat is under accelerated review and, if approved, would also be the first locally- developed medicine to hit the Chinese market even before
Chinese biotech’s global ambitions

The company has a PD-1 cancer immunotherapy, tislelizumab, in development in China, and believes it can compete in the market alongside multinationals MSD (Merck in the US) and BMS and ... Meanwhile, BeiGene is also looking to break into the still
Biopharma's Future: Made in China

and a series of sweeping reforms is now opening China’s pharma market to rapid modernisation. ... Doing business ethically and in a compliant way is incredibly important for us globally, not just in China.”.

More from intelligence
Approximately 0 fully matching, plus 45 partially matching documents found.

Latest appointments

Pharma industry appointments

Prior to this, Jenkins spent 17 years at GlaxoSmithKline (GSK) in the UK and US. ... UK. Vu, whose new post will see him further expand Concept’s presence in the US market, joins the company with over 15 years’ experience in both business development
Open Health creates new role

Joining the agency with twenty years’ biopharmaceutical industry experience, Jones’ expertise lies in market access, therapy launch and patient centric services. ... Creating a unique role within our field of expertise will enable us to offer a
W2O bolsters its commercialisation offering

Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Joining the network from Edelman, Glaze previously led the design and implementation of its US market access communications offering.
Amra appoints new VP of North American sales Jeremy Edwards

With more than 20 years’ experience in the clinical development industry, Edwards joins the company after spending five years as vice president and general manager of the US operations for Exco ... expand the US market.”.
Portland Health appoints Alfred Jackson as a partner

He said: “The opportunity to help Portland expand its impressive health footprint to the US market is an incredible opportunity. ... agency experience, senior leadership and strategic relationships across the health and government sectors to deepen our

More from appointments
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest from PMHub

Emotional Recognition using Facial Analysis

According to psychologists, a lot of emotional information can be drawn from our facial expressions, which is valuable to us as market researchers as we are interested in the emotional responses
Genetic counsellors: the new healthcare influencers?

There are more than 70, 000 different genetic testing products available on the US market in 2018 with 10 new tests entering the market daily. ... The prolific number of direct to consumer genetic tests on the market has also heightened confusion for
Shining brighter than ever

They have helped us to really highlight all of the services that we offer and show that we are a genuine full-service provider.”. ... Our workshop helped us to unearth insights about the company and its market that led to the development of a strong
Hanson Zandi

MARKET ACCESS TOOLS. Our range of market access tools includes Fast-TRAQ and Budget Impact Models. ... Market Access Strategy Associate Director. Great work, look forward to implementing this in the Pacrim.
A New Managing Director Appointed for Lighthouse Medical Communications US

growth of the group in the US market. ... client side, made him the ideal choice to head the Lighthouse Communications team in the US.